Bioqual, Inc. provides research, development, pre-clinical, consulting, and testing/assay services to commercial clients and government laboratories in the United States. The company provides research services in the areas of cancer, AIDS, hepatitis, influenza, immunology, transgenic, contraception, breeding and development of genetically defined animals, and neurobiology and behavior, as well as zika, dengue, malaria, respiratory syncytial virus, and other infectious diseases. Its services also include sample processing, virus stock generation, infectious virus quantitation, virus neutralization assays, hemagglutination inhibition assays, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides in-vivo animal model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.
Industry, Sector and Symbol
Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Phone301-251-2801
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$35.88 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date9/10/2019 (Estimated)
OptionableNot Optionable
BIOQUAL (OTCMKTS:BIOQ) Frequently Asked Questions
What is BIOQUAL's stock symbol?
BIOQUAL trades on the OTCMKTS under the ticker symbol "BIOQ."
How often does BIOQUAL pay dividends? What is the dividend yield for BIOQUAL?
BIOQUAL announced an annual dividend on Tuesday, September 11th. Investors of record on Wednesday, September 19th will be given a dividend of $0.60 per share on Wednesday, October 10th. This represents a dividend yield of 1.68%. The ex-dividend date of this dividend is Tuesday, September 18th. View BIOQUAL's Dividend History.
How were BIOQUAL's earnings last quarter?
BIOQUAL, Inc. (OTCMKTS:BIOQ) announced its earnings results on Tuesday, April, 16th. The company reported $0.52 EPS for the quarter. The firm had revenue of $9.91 million for the quarter. View BIOQUAL's Earnings History.
When is BIOQUAL's next earnings date?
Has BIOQUAL been receiving favorable news coverage?
Media coverage about BIOQ stock has trended somewhat positive on Sunday, according to InfoTrie Sentiment. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. BIOQUAL earned a media sentiment score of 1.2 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for BIOQUAL.
Who are some of BIOQUAL's key competitors?
Who are BIOQUAL's key executives?
BIOQUAL's management team includes the folowing people:
- Dr. David A. Newcomer, Chief Financial Officer (Age 58)
- Dr. Marisa St. Claire DVM, VP - Primate Biology and Medicine (Age 54)
- Dr. Mark G. Lewis, Chairman, CEO & Pres (Age 64)
- Mitch Franklin, Chief Operating Officer
- Nancy A. Madden, VP of Admin. Operations & Biosafety Officer
How do I buy shares of BIOQUAL?
Shares of BIOQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is BIOQUAL's stock price today?
One share of BIOQ stock can currently be purchased for approximately $35.80.
How big of a company is BIOQUAL?
What is BIOQUAL's official website?
How can I contact BIOQUAL?
BIOQUAL's mailing address is 9600 MEDICAL CENTER DR, ROCKVILLE MD, 20850. The company can be reached via phone at 301-251-2801.
MarketBeat Community Rating for BIOQUAL (OTCMKTS BIOQ)
MarketBeat's community ratings are surveys of what our community members think about BIOQUAL and other stocks. Vote "Outperform" if you believe BIOQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BIOQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
